Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Measuring serum antibody to human papillomavirus following infection or vaccination.

Frazer IH.

Gynecol Oncol. 2010 Jun;118(1 Suppl):S8-11. doi: 10.1016/j.ygyno.2010.04.003. Review.

PMID:
20494221
2.

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.

Olsson SE, Villa LL, Costa RL, Petta CA, Andrade RP, Malm C, Iversen OE, Høye J, Steinwall M, Riis-Johannessen G, Andersson-Ellstrom A, Elfgren K, von Krogh G, Lehtinen M, Paavonen J, Tamms GM, Giacoletti K, Lupinacci L, Esser MT, Vuocolo SC, Saah AJ, Barr E.

Vaccine. 2007 Jun 21;25(26):4931-9. Epub 2007 Apr 20.

PMID:
17499406
3.

Correlating immunity with protection for HPV infection.

Frazer I.

Int J Infect Dis. 2007 Nov;11 Suppl 2:S10-6. doi: 10.1016/S1201-9712(07)60016-2. Review.

4.

Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.

Schwarz TF.

Adv Ther. 2009 Nov;26(11):983-98. doi: 10.1007/s12325-009-0079-5. Epub 2009 Dec 18. Review.

PMID:
20024678
5.

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.

Einstein MH, Baron M, Levin MJ, Chatterjee A, Edwards RP, Zepp F, Carletti I, Dessy FJ, Trofa AF, Schuind A, Dubin G; HPV-010 Study Group..

Hum Vaccin. 2009 Oct;5(10):705-19. Epub 2009 Oct 14.

PMID:
19684472
6.
7.

Prevention strategies against the human papillomavirus: the effectiveness of vaccination.

Stanley M.

Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S19-23. Review.

PMID:
17938013
8.

Vaccines for the prevention of human papillomavirus infections.

Speck LM, Tyring SK.

Skin Therapy Lett. 2006 Jul-Aug;11(6):1-3.

9.

[HPV vaccination: principles, results and future perspectives].

Rouzier R, Uzan C, Collinet P.

J Gynecol Obstet Biol Reprod (Paris). 2007 Feb;36(1):13-8. Epub 2007 Jan 17. Review. French.

10.

Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence.

Bonanni P, Boccalini S, Bechini A.

Vaccine. 2009 May 29;27 Suppl 1:A46-53. doi: 10.1016/j.vaccine.2008.10.085. Review.

PMID:
19480962
11.

Potential mechanisms for HPV vaccine-induced long-term protection.

Stanley M.

Gynecol Oncol. 2010 Jun;118(1 Suppl):S2-7. doi: 10.1016/j.ygyno.2010.04.002. Review.

PMID:
20494220
12.

The human papillomavirus vaccines.

Ljubojević S.

Acta Dermatovenerol Croat. 2006;14(3):208.

PMID:
17010274
13.

[Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].

Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H.

Bull Acad Natl Med. 2007 Dec;191(9):1805-16; discussion 1816-7. French.

PMID:
18663976
14.

Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine.

Giuliano AR, Lazcano-Ponce E, Villa L, Nolan T, Marchant C, Radley D, Golm G, McCarroll K, Yu J, Esser MT, Vuocolo SC, Barr E.

J Infect Dis. 2007 Oct 15;196(8):1153-62. Epub 2007 Sep 17.

PMID:
17955433
15.

HPV-vaccination against cervical carcinoma: will it really work?

Gross G.

Med Microbiol Immunol. 2007 Sep;196(3):121-5. Epub 2007 Feb 21. Review.

PMID:
17318575
16.

Human papillomavirus vaccines and the potential for cross-protection between related HPV types.

Ault KA.

Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S31-3. Review.

PMID:
18499916
17.

Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines.

Hildesheim A, Markowitz L, Avila MH, Franceschi S.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/227-32. Epub 2006 Jun 19. Review.

PMID:
16950011
18.
19.

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

Joura EA, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch X, Dillner J, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Lu S, Vuocolo S, Hesley TM, Haupt RM, Barr E.

Vaccine. 2008 Dec 9;26(52):6844-51. doi: 10.1016/j.vaccine.2008.09.073. Epub 2008 Oct 16.

PMID:
18930097

Supplemental Content

Support Center